Tokyo, Japan and Cambridge, UK, 1 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces the appointment of Shinya Tsuzuki, as Head of Investor Relations. Mr. Tsuzuki ...

BestBrick Medical is a well-established medical distributor with over 30 years of deep-rooted presence in the Taiwanese healthcare market. BestBrick specializes in introducing innovative solutions and ...

NGES 4.0 leverages AI technology to enhance efficiency, refine management, and ensure compliance across various ...

Saw palmetto, a small palm plant native to the southeastern USA, is a mainstay in many elite male enhancement products. The ...

With FedRAMP® High authorization, Ceribell’s secure, cloud-based solution can be adopted across federal healthcare systems, ...

WARREN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that CD8 Technology Services LLC (“CD8”) has signed a letter of ...

Interested parties may access the live webcasts of the fireside chats by visiting the Investors & Media section of the Cytokinetics website at http://www.cytokinetics.com. The webcast replays will be ...

SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that members of the management team will present at the Citizens Life Sciences conference ...

RxSight’s management is scheduled to present on Wednesday, May 14, 2025, at 3:40 p.m. Pacific Time / 6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the ...

This year’s meeting showcased the latest advancements in burn care, fostered interdisciplinary collaboration, and celebrated the burn care community’s dedication. Burn and Plastics Senior Registar ...

PD-L1 ISAC directly activates and reprograms PD-L1-expressing myeloid cells in the TME to drive complete responses and immunological memory REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- ...

Announcement coincides with Foundation’s 25th anniversary and recent FMLA clarification supporting clinical trial access ...